Balaji Narasimhan

Ames, IA, United States of America

Balaji Narasimhan

This inventor holds 8 USPTO granted patents and 4 published patent applications. Top assignees: Iowa State University Research Foundation Inc., University of Iowa Research Foundation. Active years: 2010-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Balaji Narasimhan. Retrieved from https://idiyas.com/inventor/balaji-narasimhan-tuue2cco

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 8 

% Patents Active = 87.5

Average Co-Inventor Count = 3.2

ph-index = 2

Forward Citations = 91(Granted Patents)


Company Filing History:


Years Active: 2010-2026

Loading Chart...
8 patents (USPTO):Explore Patents

Title: An Insight into the Innovative Mind of Balaji Narasimhan

Introduction

Balaji Narasimhan, an accomplished inventor based in Ames, IA, has made significant contributions to the fields of nanotechnology and medicine. With a remarkable portfolio of seven patents, he focuses on developments that aim to improve diagnostic and therapeutic methodologies for pressing health issues, including neurodegenerative diseases and influenza.

Latest Patents

Among his noteworthy inventions, Balaji's latest patents include groundbreaking work in the realm of neurotherapeutics and immunology. His patent on **Nano-theranostics for Parkinson's Disease** introduces aggregate alpha-synuclein specific antibodies and their derivatives, designed for early diagnosis and treatment of Parkinson's Disease and related disorders. This innovation encompasses not only the antibodies but also assays, kits, and nanoparticle-encapsulated compositions that demonstrate potential in enhancing patient outcomes.

Additionally, his patent on the **Influenza Nanovaccine** outlines an innovative immunogenic composition utilizing biodegradable polyanhydride nanoparticles. These nanoparticles contain both an immunogenic protein from the Influenza Virus and an adjuvant, aiming to induce robust local and systemic immunity against this virus. This remarkable approach embodies the intersection of nanotechnology and vaccine development.

Career Highlights

Balaji Narasimhan has been associated with prestigious institutions, including the Iowa State University Research Foundation and the University of Iowa Research Foundation. His work at these research foundations highlights his commitment to furthering scientific understanding and practical applications of his inventions in both academic and industrial settings.

Collaborations

Throughout his career, Balaji has collaborated with esteemed colleagues such as Bryan Bellaire and Matthew J Kipper. These partnerships have undoubtedly enriched his research endeavors and contributed to the successful development of his patented technologies.

Conclusion

Balaji Narasimhan stands as a prominent figure in the realm of invention and innovation, particularly with his focus on improving healthcare through advanced technologies. His work has the potential to significantly impact the diagnosis and treatment of critical diseases, reflecting the intersection of creativity and science in the pursuit of better health outcomes. As an inventor, he continues to push the boundaries of research, fostering an environment where novel solutions can thrive.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…